Paper36216730
How cancer cells make and respond to interferon-I.
Cheon H and 4 others. Trends Cancer, 2023. Cited by 146 papers, by iCite.
Cite this record
ConductScience Library. How cancer cells make and respond to interferon-I. Papers, record 36216730. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36216730
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Interferon-Stimulated Gene Factor 3 | |
| Interferon-Stimulated Gene Factor 3, gamma Subunit | |
| Signal Transduction | |
| Tyrosine |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA062220 | NCI NIH HHS | United States | P01CA062220 | PubMed and NIH | NIH RePORTER |
| R01 CA252224 | NCI NIH HHS | United States | R01CA252224 | PubMed and NIH | NIH RePORTER |
| R03 CA215941 | NCI NIH HHS | United States | R03CA215941 | PubMed and NIH | NIH RePORTER |
| R21 CA252387 | NCI NIH HHS | United States | R21CA252387 | PubMed and NIH | NIH RePORTER |
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25692705 | DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity. | Immunity | 2015 | https://conductscience.org/library/papers/25692705 | PubMed |
| 2 | 31497205 | Expression profile and prognostic values of STAT family members in non-small cell lung cancer. | Am J Transl Res | 2019 | https://conductscience.org/library/papers/31497205 | PubMed |
| 3 | 30557977 | Several genes involved in the JAK-STAT pathway may act as prognostic markers in pancreatic cancer identified by microarray data analysis. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30557977 | PubMed |
| 4 | 35004284 | Oncolytic Viruses and Cancer, Do You Know the Main Mechanism? | Front Oncol | 2021 | https://conductscience.org/library/papers/35004284 | PubMed |
| 5 | 28728846 | The effects of type I interferon on glioblastoma cancer stem cells. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/28728846 | PubMed |
| 6 | 24434553 | RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24434553 | PubMed |
| 7 | 33849964 | Can Biomarkers Guide Oncolytic Virus Immunotherapy? | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33849964 | PubMed |
| 8 | 30853213 | LINE1 Derepression in Aged Wild-Type and SIRT6-Deficient Mice Drives Inflammation. | Cell Metab | 2019 | https://conductscience.org/library/papers/30853213 | PubMed |
| 9 | 28442624 | Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections. | Sci Signal | 2017 | https://conductscience.org/library/papers/28442624 | PubMed |
| 10 | 25344738 | Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. | Nat Med | 2014 | https://conductscience.org/library/papers/25344738 | PubMed |
| 11 | 34795058 | The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34795058 | PubMed |
| 12 | 34799452 | PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34799452 | PubMed |
| 13 | 31817234 | Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31817234 | PubMed |
| 14 | 28579323 | Type I Interferon in Chronic Virus Infection and Cancer. | Trends Immunol | 2017 | https://conductscience.org/library/papers/28579323 | PubMed |
| 15 | 22820642 | Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. | Nat Med | 2012 | https://conductscience.org/library/papers/22820642 | PubMed |
| 16 | 32759968 | A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses. | Cell Res | 2021 | https://conductscience.org/library/papers/32759968 | PubMed |
| 17 | 24434209 | Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses. | Cancer Cell | 2014 | https://conductscience.org/library/papers/24434209 | PubMed |
| 18 | 16490214 | The human LINE-1 retrotransposon creates DNA double-strand breaks. | J Mol Biol | 2006 | https://conductscience.org/library/papers/16490214 | PubMed |
| 19 | 24065129 | IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. | EMBO J | 2013 | https://conductscience.org/library/papers/24065129 | PubMed |
| 20 | 27791205 | Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents. | Oncotarget | 2016 | https://conductscience.org/library/papers/27791205 | PubMed |
Cited by106
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983473 | Integrated single-nucleus and spatial transcriptomics define tumour cell metaprograms and tumour microenvironment organisation in choroid plexus tumours. | Genome Med | 2026 | https://conductscience.org/library/papers/42983473 | PubMed |
| 42982877 | Deubiquitinases at the crossroads of T-cell immunity and tumor immune evasion. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42982877 | PubMed |
| 42981393 | IFNAR1 stabilization sustains CD8+ T cell persistence in IFN-high colorectal cancer liver metastases. | Sci Adv | 2026 | https://conductscience.org/library/papers/42981393 | PubMed |
| 42939477 | A Biomimetic In Vitro Model of the Pro-Inflammatory Microenvironment Recapitulates Type I/II Interferon Signaling and Refractory Acute Monocytic Leukemia. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42939477 | PubMed |
| 42744865 | Viral mimicry escape as a necessary feature of malignant transformation. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/42744865 | PubMed |
| 42512286 | Plasma-Derived sEVs from HNSCC Patients Differentially Regulate NF-κB Signaling in Macrophages Depending on the HPV Status. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512286 | PubMed |
| 42495531 | KMT5A-mediated methylation of IRF3 promotes tumor progression through immune suppression. | iScience | 2026 | https://conductscience.org/library/papers/42495531 | PubMed |
| 42428769 | Natural and Engineered Cytokines as Cancer Therapeutics. | Annu Rev Cancer Biol | 2026 | https://conductscience.org/library/papers/42428769 | PubMed |
| 42297776 | Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42297776 | PubMed |
| 42245637 | Endogenous retroviruses and response to immune checkpoint inhibitors: mechanisms, clinical evidence, and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42245637 | PubMed |
| 42200421 | Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma. | Mol Oncol | 2026 | https://conductscience.org/library/papers/42200421 | PubMed |
| 42190606 | BRCA1 deficiency induces NFκB-dependent type-I interferon signaling in fallopian tube epithelial cells. | Neoplasia | 2026 | https://conductscience.org/library/papers/42190606 | PubMed |
| 42180981 | Multiomic characterization of response and resistance to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42180981 | PubMed |
| 42112708 | Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy. | Cancer Immunol Res | 2026 | https://conductscience.org/library/papers/42112708 | PubMed |
| 41963303 | Targeting the epigenome and the integrated stress response to normalize colorectal cancer subclonal plasticity and progression. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41963303 | PubMed |
| 41959390 | Sustained interferon exposure creates a hyper-metastatic subset of melanoma cells. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959390 | PubMed |
| 41885070 | Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk Neuroblastoma. | Mol Cancer Ther | 2026 | https://conductscience.org/library/papers/41885070 | PubMed |
| 41872684 | Striking the right balance with type I interferon signalling in cancer. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/41872684 | PubMed |
| 41820027 | The Effect of Interferon Type I Adjuvant Therapy on the Lifespan and Complications of Glioma Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/41820027 | PubMed |
| 41815915 | Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41815915 | PubMed |
Genes32
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36216730
GET https://conductscience.org/api/papers/v1/36216730/references?page=2